Biomerica (BMRA) Cash from Operations Growth (3y) (2013 - 2026)
Biomerica (BMRA) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 0.50% |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | 10.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.18% |
| Nov 30, 2025 | 6.52% |
| Aug 31, 2025 | 44.56% |
| May 31, 2025 | 46.25% |
| Feb 28, 2025 | -34.68% |
| Nov 30, 2024 | 35.00% |
| Aug 31, 2024 | -170.18% |
| May 31, 2024 | -1.19% |
| Feb 29, 2024 | -9.71% |
| Nov 30, 2023 | 13.10% |
| Aug 31, 2023 | -1.58% |
| May 31, 2023 | 34.93% |
| Feb 28, 2023 | -58.05% |
| Nov 30, 2022 | -50.22% |
| Aug 31, 2022 | -477.81% |
| May 31, 2022 | -62.80% |
| Feb 28, 2022 | 123.67% |
| Nov 30, 2021 | -127.56% |
| Aug 31, 2021 | 28.06% |
| May 31, 2021 | -46.26% |